113 related articles for article (PubMed ID: 14754614)
1. Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16).
Valk PJ; Bowen DT; Frew ME; Goodeve AC; Löwenberg B; Reilly JT
Haematologica; 2004 Jan; 89(1):106. PubMed ID: 14754614
[No Abstract] [Full Text] [Related]
2. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
Side LE; Curtiss NP; Teel K; Kratz C; Wang PW; Larson RA; Le Beau MM; Shannon KM
Genes Chromosomes Cancer; 2004 Mar; 39(3):217-23. PubMed ID: 14732923
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?
Reilly JT
Br J Haematol; 2005 Jan; 128(1):18-34. PubMed ID: 15606546
[TBL] [Abstract][Full Text] [Related]
4. Clonality analysis of cell lineages in acute myeloid leukemia with inversion 16.
Chang H; Nayar R; Li D; Sutherland DR
Cancer Genet Cytogenet; 2005 Jan; 156(2):175-8. PubMed ID: 15642400
[TBL] [Abstract][Full Text] [Related]
5. A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion.
Billio A; Steer EJ; Pianezze G; Svaldi M; Casin M; Amato B; Coser P; Cross NC
Haematologica; 2002 May; 87(5):ECR15. PubMed ID: 12010678
[No Abstract] [Full Text] [Related]
6. Two more inv(16) acute myeloid leukemia cases with infrequent CBFbeta-MYH11 fusion transcript: clinical and molecular findings.
Martinelli G; Ottaviani E; Buonamici S; Isidori A; Malagola M; Piccaluga P; Baccarani M
Haematologica; 2002 May; 87(5):554-5. PubMed ID: 12010674
[No Abstract] [Full Text] [Related]
7. Morphologic characterization of acute myeloid leukemia with cytogenetic or molecular evidence of t(8;21), t(15;17), inv(16) and 11q23 abnormalities.
Rozman M; Navarro JT; Domingo A; Ayats R; Vallespí T; Gallart M; Florensa L;
Haematologica; 2002 Aug; 87(8):886-7. PubMed ID: 12161368
[No Abstract] [Full Text] [Related]
8. Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation.
Suzuki M; Abe A; Kiyoi H; Murata M; Ito Y; Shimada K; Morishita Y; Kinoshita T; Naoe T
Leukemia; 2006 Jun; 20(6):1168-9. PubMed ID: 16557239
[No Abstract] [Full Text] [Related]
9. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
[TBL] [Abstract][Full Text] [Related]
10. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.
Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY
Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351
[TBL] [Abstract][Full Text] [Related]
11. FLT3 mutations in myeloid sarcoma.
Ansari-Lari MA; Yang CF; Tinawi-Aljundi R; Cooper L; Long P; Allan RH; Borowitz MJ; Berg KD; Murphy KM
Br J Haematol; 2004 Sep; 126(6):785-91. PubMed ID: 15352981
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
[TBL] [Abstract][Full Text] [Related]
13. RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma.
Sharma MK; Zehnbauer BA; Watson MA; Gutmann DH
Neurology; 2005 Oct; 65(8):1335-6. PubMed ID: 16247081
[No Abstract] [Full Text] [Related]
14. A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22).
Kim M; Lim J; Kim Y; Han K; Kang CS; Kim HJ; Min WS
Leukemia; 2006 Apr; 20(4):746-8. PubMed ID: 16437154
[No Abstract] [Full Text] [Related]
15. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type.
Chen W; Jones D; Medeiros LJ; Luthra R; Lin P
Br J Haematol; 2005 Sep; 130(5):726-8. PubMed ID: 16115128
[TBL] [Abstract][Full Text] [Related]
16. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
18. [Study of trisomy 22 and inversion 16 in acute myeloid leukemia].
Zhou HF; Li JY; Pan JL; Qiu HR; Chen LJ; Hu JY; Shen YF; Xu W; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):11-4. PubMed ID: 17649718
[TBL] [Abstract][Full Text] [Related]
19. Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely.
Martinelli G; Rondoni M; Buonamici S; Ottaviani E; Piccaluga PP; Malagola M; Baccarani M
Haematologica; 2004 Apr; 89(4):495-7. PubMed ID: 15075086
[TBL] [Abstract][Full Text] [Related]
20. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.
Paschka P; Marcucci G; Ruppert AS; Mrózek K; Chen H; Kittles RA; Vukosavljevic T; Perrotti D; Vardiman JW; Carroll AJ; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2006 Aug; 24(24):3904-11. PubMed ID: 16921041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]